951 640

Cited 0 times in

한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성(Ⅳ): 과거 항정신병약물 치료력이 약물 효과 및 알고리듬 적용에 미치는 영향

DC Field Value Language
dc.contributor.author이홍식-
dc.contributor.author조현상-
dc.date.accessioned2015-06-10T12:27:48Z-
dc.date.available2015-06-10T12:27:48Z-
dc.date.issued2006-
dc.identifier.issn1017-5717-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/109847-
dc.description.abstractObjective:The Korean Medication Algorithm for the Treatment of Schizophrenia was developed by the extensive review and questionnaires. To evaluate the impact of a history of antipsychotic treatments on clinical response and algorithm application, using the data derived from the feasibility study of the Medication Algorithm for patients with schizophrenia. Method:Outcomes of treatment with the Medication Algorithm for 108 schizophrenics up to 4 months are presented. Measures of changes included clinical symptoms, functioning, and side effects. Comparison was done between patients with and without a history of antipsychotic treatments. Results:100 individuals (with a history=71;without a history=29) were analyzed for the comparison. Most of subjects without a history of antipsychotic treatments were administered on risperidone in the initial treatment. When compared with the subjects with a treatment history, the subjects without a history showed better treatment effects on clinical symptoms at the first evaluation. At 4-month, there were similar effects between the two groups except negative symptoms, in which the group with a history showed significantly more improvement than without a history. There were no significant differences in assessment of subjective opinion and well-being to drugs and quality of life, and objective evaluation of drug side effects. Among the subjects with a history, the ones starting with stage 1 showed higher positive symptoms, anxiety scores, and briefer duration of antipsychotic exposure than the ones starting with stage 2 or more advanced. Conclusion:This study suggests that despite some limitation, an antipsychotic treatment history may have an impact on application of medication algorithm and these data will be helpful for revision of the Medication Algorithm for the Treatment of Schizophrenia.-
dc.description.statementOfResponsibilityopen-
dc.format.extent162~173-
dc.relation.isPartOfKorean Journal of Psychopharmacology (대한정신약물학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.title한국형 정신분열병 약물치료 알고리듬의 임상 적용 가능성(Ⅳ): 과거 항정신병약물 치료력이 약물 효과 및 알고리듬 적용에 미치는 영향-
dc.title.alternativeThe Feasibility Test of Korean Medication Algorithm for the Treatment with Schizophrenic Patients(IV):Influences of a History of Antipsychotic Treatment on Effectiveness and Algorithm Application-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Psychiatry (정신과학)-
dc.contributor.googleauthor조현상-
dc.contributor.googleauthor권준수-
dc.contributor.googleauthor박원명-
dc.contributor.googleauthor김창윤-
dc.contributor.googleauthor신영철-
dc.contributor.googleauthor전덕인-
dc.contributor.googleauthor이상열-
dc.contributor.googleauthor최용성-
dc.contributor.googleauthor이홍식-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA03332-
dc.contributor.localIdA03928-
dc.relation.journalcodeJ02107-
dc.subject.keywordSchizophrenia-
dc.subject.keywordMedication algorithm-
dc.subject.keywordFeasibility-
dc.subject.keywordAntipsychotic history-
dc.contributor.alternativeNameLee, Hong Shick-
dc.contributor.alternativeNameCho, Hyun Sang-
dc.contributor.affiliatedAuthorLee, Hong Shick-
dc.contributor.affiliatedAuthorCho, Hyun Sang-
dc.rights.accessRightsfree-
dc.citation.volume17-
dc.citation.number2-
dc.citation.startPage162-
dc.citation.endPage173-
dc.identifier.bibliographicCitationKorean Journal of Psychopharmacology (대한정신약물학회지), Vol.17(2) : 162-173, 2006-
dc.identifier.rimsid50314-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.